🇺🇸 FDA

Company profile · Sponsor

C4

C4 Therapeutics

CCCC · NYSE biotech WATERTOWN, MA, USA
Pipeline
4
Drugs
0
Patents
8

Quick answer

C4 (CCCC) is a biotech company. headquartered in WATERTOWN, MA, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker CCCC
Exchange NYSE
Company type biotech
Headquarters WATERTOWN, MA, USA
SEC CIK 0001662579

Pipeline (4)

Search pipeline →

  1. cemsidomide

    C4

    Multiple Myeloma

    phase 2 small molecule active

    2 trials

  2. CFT1946

    C4

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  3. CFT8634

    C4

    Synovial Sarcoma

    phase 1 small molecule terminated

    1 trial

  4. Cemsidomide

    C4

    Multiple Myeloma (MM)

    phase 1 small molecule active

    1 trial

Patents (8)

Search patents →

  1. US 12421220

    Bicyclic-substituted glutarimide cereblon binders

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12371442

    Isoindolinone and indazole compounds for the degradation of EGFR

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12227504

    Spirocyclic compounds

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12180225

    N/O-linked degrons and degronimers for protein degradation

    Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12157735

    Compounds for targeted degradation of BRD9

    Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12091397

    Dihydroquinolinones for medical treatment

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12076405

    Heterocyclic degronimers for target protein degradation

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12048748

    Spirocyclic degronimers for target protein degradation

    Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is C4?

C4 (CCCC) is a biotech company. headquartered in WATERTOWN, MA, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does C4 sponsor?

We track 4 ClinicalTrials.gov-linked programs for C4, including cemsidomide and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does C4 company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.